US Bancorp DE Lowers Stock Position in ARK Genomic Revolution ETF (BATS:ARKG)

US Bancorp DE cut its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 16.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,631 shares of the company’s stock after selling 1,278 shares during the period. US Bancorp DE’s holdings in ARK Genomic Revolution ETF were worth $170,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in ARKG. Cetera Investment Advisers boosted its holdings in ARK Genomic Revolution ETF by 290.7% during the 1st quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after acquiring an additional 104,831 shares during the period. Main Management ETF Advisors LLC boosted its stake in shares of ARK Genomic Revolution ETF by 2.3% in the second quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock valued at $64,678,000 after purchasing an additional 62,470 shares during the period. Mercer Global Advisors Inc. ADV grew its holdings in shares of ARK Genomic Revolution ETF by 901.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 28,943 shares of the company’s stock valued at $680,000 after purchasing an additional 26,053 shares in the last quarter. Headlands Technologies LLC grew its holdings in shares of ARK Genomic Revolution ETF by 5,878.2% in the second quarter. Headlands Technologies LLC now owns 21,163 shares of the company’s stock valued at $497,000 after purchasing an additional 20,809 shares in the last quarter. Finally, Prudential PLC increased its stake in ARK Genomic Revolution ETF by 15.0% during the 2nd quarter. Prudential PLC now owns 140,170 shares of the company’s stock worth $3,326,000 after buying an additional 18,300 shares during the period.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG stock opened at $24.16 on Friday. The firm has a 50 day simple moving average of $24.91 and a 200 day simple moving average of $25.16.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.